Helicore Bioventures I, Inc.
Biotechnology company · New York, United States
Helicore Bioventures I, Inc. is a biotechnology company headquartered in New York, United States. Its earliest recorded incorporation is in 2023. It has reported private securities offerings to the US SEC, most recently $15 million sold in a notice filed in 2024.
Helicore Bioventures I at a glance
What does Helicore Bioventures I do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $15 million sold (2024).
Frequently asked questions about Helicore Bioventures I
Where is Helicore Bioventures I headquartered?
Helicore Bioventures I, Inc. is headquartered in New York, United States.
What does Helicore Bioventures I do?
Helicore Bioventures I, Inc. is a biotechnology company.
When was Helicore Bioventures I founded?
The earliest incorporation on record for Helicore Bioventures I, Inc. is in 2023, according to public company registers.
Similar companies
- Lexeo Therapeutics, Inc.New York City, New York, United States
- MiNK Therapeutics, Inc.New York City, New York, United States
- IN8BIO, Inc.New York City, New York, United States
- Anavex Life Sciences Corp.New York City, New York, United States
- Brainstorm Cell Therapeutics Inc.New York City, New York, United States
- Bioincept LLCNew York City, New York, United States
- Protara Therapeutics, Inc.New York City, New York, United States
- Ancilia Biosciences, Inc.New York City, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences